An FT investigation has found a thriving market for stem cell therapies in the US promising longer, healthier lives. Experts say such claims are dangerous
Related stories
New vape tax made me swap e-cigs for dartboards
New electric car 'make or break for Jaguar'
Hygiene poverty at tipping point, charity warns
Funding to help more people access healthy food
EU’s top trade envoy in China for tense talks over cars
'Come all the way' back to EU, French finance minister tells UK